Nova Leah, the Dundalk headquartered medical device security company which recently announced 78 jobs, has announced a significant global customer win.
Fresenius Medical Care, the world's largest provider of dialysis products and services,, has chosen to implement Nova Leah's cybersecurity risk management tool SelectEvidence®, the world's first expert cybersecurity risk management system for connected medical devices.
Nova Leah specialise in cybersecurity risk management software solutions for the medical device and healthcare industry. It is the first company to develop an intelligent security risk management solution for use by manufacturers, vendors and healthcare providers.
The SelectEvidence is the result of a five-year R&D programme at DkIT.